Key result
Lower T-wave vector magnitude (<0.30 mV) was associated with an elevated risk of cardiac events in LQT2 mutation carriers with normal QTc (HR 2.64; 95% CI 1.64-4.24; P<0.001), specifically in women.
Why the study?
LQTS mutation carriers have an elevated cardiac event risk even without QTc prolongation, but mutation penetrance may be reflected in abnormal T-wave shape in KCNH2 mutation carriers.
Does lower T-wave vector magnitude predict cardiac events in KCNH2 mutation carriers with normal QTc values?
Cohort (n=1,120)
Does lower T-wave vector magnitude predict cardiac events in KCNH2 mutation carriers with normal QTc values?
Hazard Ratio: 2.64 (95% CI 1.64–4.24)
p-value: p=<.001
T-wave morphology quantified as repolarization vector magnitude from a standard 12-lead ECG predicts cardiac events in female KCNH2-mutation carriers without QTc prolongation.
May support ECG risk stratification in female LQT2 carriers with normal QTc; leaves open prospective validation before practice change.
Introduction Long QT syndrome (LQTS) mutation carriers have elevated the risk of cardiac events even in the absence of QTc prolongation; however, mutation penetrance in patients with normal QTc may be reflected in abnormal T‐wave shape, particularly in KCNH2 mutation carriers. We aimed to assess whether the magnitude of a three‐dimensional T‐wave vector (TwVM) will identify KCNH2‐mutation carriers with normal QTc at risk for cardiac events. Methods Adult LQT2 patients with QTc < 460 ms in men and <470 ms in women (n = 113, age 42 ± 16 years, 43% male) were compared with genotype‐negative family members (n = 1007). The TwVM was calculated using T‐wave amplitudes in leads V6, II, and V2 as the square root of (TV6 2 + TII 2 + (0.5*TV2) 2 ). Cox regression analysis adjusted for gender and time‐dependent beta‐blocker use was performed to assess cardiac event (CE) risk, defined as syncope, aborted cardiac arrest, implantable cardioverter‐defibrillator therapy, or sudden death. Results Dichotomized by median of 0.30 mV, lower TwVM was associated with elevated CE risk compared to those with high TwVM (HR = 2.95, 95% CI, 1.25‐6.98, P = .014) and also remained significant after including sex and time‐dependent beta‐blocker usage in the Cox regression analysis (HR = 2.64, 95% CI, 1.64‐4.24, P < .001). However, these associations were found only in women but not in men who had low event rates. Conclusion T‐wave morphology quantified as repolarization vector magnitude using T‐wave amplitudes retrieved from standard 12‐lead electrocardiogram predicts cardiac events risk in LQT2 women and appears useful for risk stratification of KCNH2‐mutation carriers without QTc prolongation.
No takes yet. Share an insight, caveat, or question.
Cortez et al. (2019) conducted a cohort in Long QT syndrome (LQT2) with normal QTc (n=1,120). Lower T-wave vector magnitude (<0.30 mV) vs. High T-wave vector magnitude (≥0.30 mV) was evaluated on Cardiac event (syncope, aborted cardiac arrest, implantable cardioverter-defibrillator therapy, or sudden death) (HR 2.64, 95% CI 1.64-4.24, p=<.001). Lower T-wave vector magnitude (<0.30 mV) was associated with an elevated risk of cardiac events in LQT2 mutation carriers with normal QTc (HR 2.64; 95% CI 1.64-4.24; P<0.001), specifically in women.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: